Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. Client, organization or corporation number: 371

Refine By

Document Type Registrations Status
Activity Type Subject Matter of the Lobbying Activity Government Institutions

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Advanced Registry Search Results

Results: 1-50 of 821
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Ed Morgan , Director General | Health Canada (HC)
    Communication Date: 2022-05-31
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Ajay Rakhra , Chief of Staff | House of Commons
    Communication Date: 2022-05-16
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Daniel Saad, A/Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    Communication Date: 2022-05-06
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stephen Lucas , Deputy Minister | Health Canada (HC)
    Communication Date: 2022-05-06
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Simon Kennedy - , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Communication Date: 2022-05-06
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Sandenga Yeba, Senior Policy Advisor | Health Canada (HC)
    Communication Date: 2022-04-25
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Luc Thériault, Member of Parliament | House of Commons
    Communication Date: 2022-04-22
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jean-sebastien Bock , Director of Policy | Health Canada (HC)
    Communication Date: 2022-04-19
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jillian White, Director of Policy | Global Affairs Canada (GAC)
    • Laurence Harvey , Senior Policy Advisor | Global Affairs Canada (GAC)
    • Zachary Nixon , Senior Special Assistant Stakeholder Relations and Regional Affairs | Global Affairs Canada (GAC)
    Communication Date: 2022-03-18
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Eric Belair , Associate Assistant Deputy Minister | Health Canada (HC)
    Communication Date: 2022-03-07
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Susan Fitzpatrick, Assistant Deputy Minister | Health Canada (HC)
    Communication Date: 2022-02-23
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Simon Kennedy , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Communication Date: 2022-02-15
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Communication Date: 2022-02-15
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Hamzawi Nancy , Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Communication Date: 2022-02-11
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jessica Fullerton , Policy Advisor, Office of the Minister of Intergovernmental Affairs, Infrastructure and Communities | Infrastructure Canada (INFC)
    Communication Date: 2022-02-10
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Rebecca Caldwell , Senior Policy Advisor | Prime Minister's Office (PMO)
    Communication Date: 2022-02-04
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Communication Date: 2022-02-01
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jean- Sebastien Bock, Director of Policy | Health Canada (HC)
    Communication Date: 2022-01-17
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Ajay Rakhra , Chief of Staff | House of Commons
    • Rechie Valdez , Member of Parliament | House of Commons
    Communication Date: 2022-01-11
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Holly Duggan, Director of Outreach and Stakeholder Relations | House of Commons
    • Alex MacDonald, Policy Advisor, Health, Office of the Leader of the Opposition | House of Commons
    Communication Date: 2021-12-15
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Simon Kennedy , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Communication Date: 2021-12-10
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Leslyn Lewis, Member of Parliament | House of Commons
    Communication Date: 2021-12-09
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Eric Belair , Associate Assistant Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Federal Lead and Assistant Deputy Minister | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    Communication Date: 2021-12-03
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jean-Yves Duclos , Minister of Health | Health Canada (HC)
    • Jean-Sébastien Bock, Director of Policy | Health Canada (HC)
    Communication Date: 2021-12-02
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Elliott Lockington , Chief of Staff | Finance Canada (FIN)
    Communication Date: 2021-12-02
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Steven Outhouse , Deputy Chief of Staff, Office of the Leader of the Official Opposition | House of Commons
    Communication Date: 2021-12-02
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jean-Sébastien Bock , Director of Policy | Health Canada (HC)
    Communication Date: 2021-12-01
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Dylan Marando, Senior Policy Advisor | Prime Minister's Office (PMO)
    Communication Date: 2021-11-26
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Communication Date: 2021-11-26
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jean-Sébastien Bock, Director of Policy | Health Canada (HC)
    Communication Date: 2021-11-26
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Dominic LeBlanc, Minister of Intergovernmental Affairs, Infrastructure and Communities | House of Commons
    • Brandan Rowe, Director of Strategic Planning | Privy Council Office (PCO)
    • Kevin Lavigne, Minister’s Office Deputy Chief of Staff | Privy Council Office (PCO)
    Communication Date: 2021-11-12
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stan Kutcher, Senator | Senate of Canada
    Communication Date: 2021-11-11
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Communication Date: 2021-11-05
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Susan Fitzpatrick, Assistant Deputy Minister | Health Canada (HC)
    Communication Date: 2021-10-15
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Communication Date: 2021-08-17
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Communication Date: 2021-08-11
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    Communication Date: 2021-07-30
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Jason Easton, Chief of Staff, Minister of International Trade | Global Affairs Canada (GAC)
    Communication Date: 2021-07-21
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Communication Date: 2021-07-21
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)
    Communication Date: 2021-07-19
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Erin O'Toole, Member of Parliament | House of Commons
    Communication Date: 2021-06-21
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Susan Fitzpatrick, Assistant Deputy Minister | Health Canada (HC)
    Communication Date: 2021-06-18
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Communication Date: 2021-06-18
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Terry Duguid, Member of Parliament | House of Commons
    Communication Date: 2021-06-10
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Communication Date: 2021-06-08
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Tom Kmiec, Member of Parliament | House of Commons
    Communication Date: 2021-06-01
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Luc Thériault, Member of Parliament | House of Commons
    Communication Date: 2021-05-30
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Chris D’Entremont, Member of Parliament | House of Commons
    Communication Date: 2021-05-28
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Francesco Sorbara, Member of Parliment | House of Commons
    Communication Date: 2021-05-20
    Innovative Medicines Canada / Médicaments novateurs Canada
    In-house Organization
    Designated Public Office Holders:
    • Ali Ehsassi, Member of Parliament | House of Commons
    Communication Date: 2021-05-20

Date Modified: